维普期刊资源整合服务平台（V6.5）

59篇 您的检索式：作者名="Segreti"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Bacteriologic and clinical applications of a new extended-spectrum parental cephalosporin显示文摘	Levin S	1996	Am J Med1996，100，6：	1
2	Osinophilic pneumonia in an asthmatic patient treated with omalizumab therapy:frme-fruste of Churg-Strauss syndrome显示文摘	Cazzola M Mura Segreti A	2009	Allergy2009，64，9：	1
3	Osinophilic pneumonia in an asthmatic patient treated with omalizumab therapy:forme-fruste of Churg-Strauss syndrome显示文摘	Cazzola M Mura M Segreti A	2009	Allergy2009，64，9：	1
4	Eosinophilie pneumonia in an asth- matic patient treated with omalizumab therapy: forme -fnste of Churg - Strauss syndrome显示文摘	Cazzo\|a M Mura M Segreti A	2009	Allergy2009，64，9：	1
5	Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting 显示文摘	SEGRETI J HOUSE H R Siegel R E	2005	Am J Med2005，118，7：	1
6	Overview of the epidemiological profile and laboratory detection of extended-spectrum-β-lactamases显示文摘	Pfaller MA Segreti J	2006	Clin Infect Dis2006，424，：	1
7	A multi-center, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil intreatment of adults with community-acquired penumonia显示文摘	File TM Jr Segreti J Dunbar L	1997	Antimicrob Agents Chemother1997，41，9：	1
8	Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosperin显示文摘		1999	Am J Med1999，100，：	1
9	An update on bronchodilators in Phase Ⅰ and Ⅱ clinical trials显示文摘	Cazzola M Rogliani P Segreti A et aI	2012	Expert Opin Investig Drugs2012，21，10：	1
10	Emerging drugs for chronic obstructive pulmonary disease显示文摘	Matera MG Calzetta L Segreti A	2012	Expert Opin Emerg Drugs2012，17，1：	1
11	Effect of daptomycin for the treatment of patients with infectious endocarditis caused by resistant organism显示文摘	Segreti	2006	Pharmactherapy2006，26，3：	1
12	Efficacy of current agents used in the treatment of gram-positive infections and the consequences of resistance显示文摘	Segreti J	2005	Clin Microbiol Infect2005，11，3：	1
13	Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases显示文摘	Pfaller MA Segreti J	2006	Clin Infect Dis2006，42，4：	1
14	A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or ceftriaxone axetil in treat ment of adults with community-acquired pneumonia显示文摘	File TM Jr Segreti Dunbar L	1997	Antimicrob Agents Chemother1997，41，5：	1
15	A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-aquired pneumonia 显示文摘	Segreti J Dunbar L	1997	Antimicrob Agents Chemother1997，41，：	1
16	Comorbiditics of asthma:current knowledge and future research needs显示文摘	Cazzola M Segreti A Calzetta L		0，，01：	1
17	Differential patterns of ac- tivity and functional connectivity in emotion processing neural circuitry to angry and happy faces in adolescents with and without suicide at- tempt显示文摘	Pan LA Hassel S Segreti AM	2013	Psychological Medicine2013，43，10：	1
18	A muhicenter,randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of aduhs with community-acquired pneumonia显示文摘	File T M Jr Segreti J Dunbar L	1997	Antimicrob Agents Chemother1997，41，9：	1
19	Diacylglycerol acyhransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster显示文摘	King A J Segreti J A Larson K J	2009	J Pharmacol Exp Ther2009，330，2：	1
20	In vivo efficacy of acyl CoA: diacylglycerol acyhransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia 显示文摘	King A J Segreti J A Larson K J	2010	Eur J Pharmaeol2010，637，13：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示